Log in to save to my catalogue

CAR T cell immunotherapy for human cancer

CAR T cell immunotherapy for human cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2018021177

CAR T cell immunotherapy for human cancer

About this item

Full title

CAR T cell immunotherapy for human cancer

Publisher

United States

Journal title

Science (American Association for the Advancement of Science), 2018-03, Vol.359 (6382), p.1361-1365

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Adoptive T cell transfer (ACT) is a new area of transfusion medicine involving the infusion of lymphocytes to mediate antitumor, antiviral, or anti-inflammatory effects. The field has rapidly advanced from a promising form of immuno-oncology in preclinical models to the recent commercial approvals of chimeric antigen receptor (CAR) T cells to treat...

Alternative Titles

Full title

CAR T cell immunotherapy for human cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2018021177

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2018021177

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.aar6711

How to access this item